📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Assessing early therapeutic response to bevacizumab in primary breast cancer using magnetic resonance imaging and gene expression profiles. (2011)

First Author: Mehta S

Attributed to: Integrated Modelling of Functional Imaging and Gene Expression Data for Personalised Cancer Therapy funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/jncimonographs/lgr027

PubMed Identifier: 22043045

Publication URI: http://europepmc.org/abstract/MED/22043045

Type: Journal Article/Review

Volume: 2011

Parent Publication: Journal of the National Cancer Institute. Monographs

Issue: 43

ISSN: 1052-6773